Home Business Kyle Bass’ Fund Takes 5 Percent Stake In J.C. Penney

Kyle Bass’ Fund Takes 5 Percent Stake In J.C. Penney

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

J.C. Penney Company, Inc. (NYSE:JCP) just got rid of activist investor Bill Ackman, but now another major hedge fund manager has taken an interest in the company. Kyle Bass, who manages Hayman Capital Management, has disclosed that the fund holds a 5.2 percent stake in the aging retailer. That makes bass one of the company’s biggest shareholders.

Kyle Bass' Fund Takes 5 Percent Stake In J.C. Penney

Filing shows J.C. Penney stake

The disclosure came via a filing with the Securities and Exchange Commission. It shows that Hayman Capital and its related funds now hold more than 11.4 million shares of J.C. Penney Company, Inc. (NYSE:JCP). Street Insider notes that Hayman didn’t own any shares of the retailer at the end of the June quarter, which means all of them were purchased within the last two months.

The news comes after Ackman made a deal to sell off his entire stake in the retail chain. Last week it was revealed via another regulatory filing that Perry Capital bought 3 million of Ackman’s shares. Ackman’s stake had been about 18 percent of the company

J.C. Penney still struggling

Shares of J.C. Penney Company, Inc. (NYSE:JCP) rose 1 percent in early Tuesday morning trading. The company has struggled to regain its prominence over the last few years, most recently under former CEO Ron Johnson, who was brought in by Ackman. Previous CEO Myron Ullman was brought back to the retail chain to help stabilize it, and since then the changes have been happening rapidly.

In addition to bringing back the couponing and discounting strategy previously practiced by the department store chain, the company also announced that it was adopting a poison pill to prevent shareholders from taking over the company. Ackman’s stake had been covered by outstanding agreements, so it did not trigger that poison pill. However, it will have an effect on any further shares acquired by large hedge funds like Hayman or Perry.

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Michelle Jones
Editor

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.